Health Policy Advocacy: Moving Mountains from Reports to Real Change
Anna Dé, Founder and Senior Health Policy Advisor at Anna Dé Healthcare Policy Consultancy, shared a post on LinkedIn:
“It’s the elephant in the room.
Across health policy, patient advocacy and communications – we all know the pattern:
- Beautiful reports.
- Slick campaigns.
- But too often, calls to action are vague, performative or overloaded.
This means:
- No policy shift.
- No budget change.
- No real impact.
We keep producing materials that look good…but go nowhere.
And until now, no one was really talking about it.
So we did something about it.
Michael George and I created the Moving Mountains Framework – a practical, human-centred approach to health policy and advocacy that actually creates change.
- Momentum
- Community
- Pressure
That’s what moves systems – not a lonely PDF….
In this new piece, we break down the 5 steps behind the framework and how to move from publishing reports… to transforming lives.
Read the article here.
How many of us have worked on reports that looked great – but didn’t lead to change? Why does it keep happening?
Drop an elephant in the comments if this resonates.
Time to name it and move it.
Let’s stop collecting dust and start moving mountains.
— Anna Dé and Michael George”
Read more on Hemostasis Today.
-
Sep 14, 2026, 07:37Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
-
Sep 14, 2026, 07:29Eric Topol – Will AI Replace Clinicians?
-
Sep 14, 2026, 07:19Ruhi Mehra: The Evolving Science of Stem Cell Enumeration
-
Sep 14, 2026, 07:05Don’t Overlook Superficial Clots – World Thrombosis Day
-
Sep 14, 2026, 06:55Transforming Hemophilia A Treatment with Bispecific Antibodies – NEJM Group
-
Sep 14, 2026, 06:51Alexander Hof: Species-Specific Roles of MPO Deficiency
-
Sep 14, 2026, 06:36Patrick Badertscher: PVI With vs Without Posterior Wall Isolation in Persistent AF
-
Sep 14, 2026, 06:31Mona Ranade: Can Mechanical Thrombectomy Play a Role in Septic Thrombophlebitis?
-
Sep 14, 2026, 06:30Alexsander Santiago: Tranexamic Acid – Why Timing Matters in Critical Bleeding